Recall of Device Recall XACT Carotid Stent System

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Abbott Vascular-Cardiac Therapies dba Guidant Corporation.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    53477
  • Event Risk Class
    Class 2
  • Event Number
    Z-1152-2010
  • Event Initiated Date
    2009-03-19
  • Event Date Posted
    2010-03-16
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2012-03-30
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Stent, carotid - Product Code NIM
  • Reason
    Abbott vascular is initiating a recall on the xact carotid stent system because the product was distributed prior to approval of a pma supplement for a manufacturing line move between sites. there are no product quality issues associated with this action.
  • Action
    Notification was sent out to all consignees about the product recall. Representatives from Abbott Vascular personally visited consignees and removed product from site.

Device

  • Model / Serial
    Lot Number: 9011951
  • Product Classification
  • Device Class
    3
  • Implanted device?
    Yes
  • Distribution
    Nationwide: GA, NY, IN, LA, MA and PA
  • Product Description
    Xact 9 mm x 20 mm x 136 cm (Part Number 82089-01) || The Xact Carotid Stent System, used in conjunction with Emboshield Embolic Protection System is indicated for the improvement of the lumen diameter of carotid arteries in patients considered at high risk for adverse events from carotid endarterectomy who require percutaneous carotid angioplasty and stenting for occlusive artery disease.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Abbott Vascular-Cardiac Therapies dba Guidant Corporation, 26531 Ynez Rd, Temecula CA 92591-4630
  • Source
    USFDA